scholarly journals Essential Role of Quantum Science and Nanoscience in Antiviral Strategies

2021 ◽  
Author(s):  
Mina Zare ◽  
Mika Sillanpää ◽  
Seeram Ramakrishna

The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) caused the pandemic COVID-19 disease since December 2019 highlights the importance of developing efficient antiviral strategies to prevent and treat viral infection. Virus...

2004 ◽  
Vol 78 (21) ◽  
pp. 12090-12095 ◽  
Author(s):  
Andrea Marzi ◽  
Thomas Gramberg ◽  
Graham Simmons ◽  
Peggy Möller ◽  
Andrew J. Rennekamp ◽  
...  

ABSTRACT The lectins DC-SIGN and DC-SIGNR can augment viral infection; however, the range of pathogens interacting with these attachment factors is incompletely defined. Here we show that DC-SIGN and DC-SIGNR enhance infection mediated by the glycoprotein (GP) of Marburg virus (MARV) and the S protein of severe acute respiratory syndrome coronavirus and might promote viral dissemination. SIGNR1, a murine DC-SIGN homologue, also enhanced infection driven by MARV and Ebola virus GP and could be targeted to assess the role of attachment factors in filovirus infection in vivo.


Author(s):  
Ajay I. Patel ◽  
Pooja R. Maru ◽  
Ashok B. Patel ◽  
Amitkumar J. Vyas ◽  
Nilesh K. Patel

The Coronavirus Disease 2019 (COVID-19) is caused by severe acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection Attack mainly on the immune system of the body. The current pandemic situation of COVID-19 has broken the social-economical Condition of the World. The Available Allopathic drug Paramedical system is attempting to manage the symptoms. But, there are no significant effects of the available drug system. So, it is better to move toward a supplement system that improves the body's immune system. Herbs, Minerals, and Vitamins can be boosting body immunity and prevent the respiratory Viral Disease SARS-CoV-2. It gives its response in the Primary Stage of COVID-19. So, it is better to towards the natural herbals, Minerals, and vitamins which can improve the immunity of the body and it can possibly prevent the viral infection.


2021 ◽  
Author(s):  
Wenying Gao ◽  
Guangquan Li ◽  
Simin Zhao ◽  
Hong Wang ◽  
Chen Huan ◽  
...  

Ubiquitination plays an important role in human immunodeficiency virus-1 (HIV-1) infection. HIV proteins such as Vif and Vpx mediate the degradation of the host proteins APOBEC3 and SAMHD1, respectively, through the proteasome pathway. However, whether deubiquitylating enzymes play an essential role in HIV-1 infection is largely unknown. Here, we demonstrate that the deubiquitinase, USP21, potently inhibits HIV-1 production by indirectly downregulating the expression of HIV-1 trans-activator of transcription (Tat), which is essential for transcriptional elongation in HIV-1. USP21 deubiquitylates Tat via its deubiquitinase activity, but a stronger ability to reduce Tat expression compared to Ub-KO showed that other mechanisms may contribute to USP21-mediated inhibition of Tat. Further investigation showed that USP21 downregulates cyclin T1 mRNA levels by increasing methylation of histone K9 in the promoter of cyclin T1, a subunit of the positive transcription elongation factor b (P-TEFb) that interacts with Tat and transactivation response element (TAR) and is required for transcription stimulation and Tat stability. Moreover, USP21 had no effect on the function of other HIV-1 accessory proteins, including Vif, Vpr, Vpx, and Vpu, indicating that USP21 was specific to Tat. These findings improve our understanding of USP21-mediated functional suppression of HIV-1 production. Importance Ubiquitination plays an essential role in viral infection. Deubiquitinating enzymes (DUBs) reverse ubiquitination by cleaving ubiquitins from target proteins, thereby affecting viral infection. The role of the members of the USP family, that comprises the largest subfamily of DUBs, is largely unknown in HIV-1 infection. Here, we screened a series of USP members and found that USP21 inhibits HIV-1 production by specifically targeting Tat, but not the other HIV-1 accessory proteins. Further investigations revealed that USP21 reduces Tat expression in two ways. First, USP21 deubiquitinates polyubiquitinated Tat causing Tat instability, and second USP21 reduces the mRNA levels of cyclin T1 (CycT1), an important component of P-TEFb, that leads 56 to Tat downregulation. Thus, in this study, we report a novel role of the deubiquitinase, USP21, in HIV-1 viral infection. USP21 represents a potentially useful target for the development of novel anti-HIV drugs.


Author(s):  
Kavya Srinivasan ◽  
Ashutosh Pandey ◽  
Sundararajan Venkatesh

The recent emergence of Severe Acute Respiratory Syndrome-Corona Virus 2 (SARS-CoV-2) in late 2019 and its spread worldwide caused an acute pandemic of Coronavirus disease 19 (COVID-19). COVID-19 pathologies are currently under intense scrutiny as its outbreak led to immense and urgent changes worldwide. Although many theories have been introduced on how SARS-CoV-2 enters the host, the ACE-2 receptor is shown to be the primary mechanism of SARS-CoV-2 entry. However, the mechanism behind the establishment and pathology of infection is poorly understood. As recent studies show that host mitochondria play an essential role in virus-mediated innate immune response, in this review, we will discuss, in detail, the entry and progression of SARS-CoV-2 and how mitochondria play a role in the establishment of viral infection and the development of an immune response, whether it is beneficial or not. We will also review the possible treatments that could be used to prevent the surgency of COVID-19 infection with respect to the role of mitochondria. Understanding the mitochondria-mediated SARS-CoV-2 establishment may provide a unique mechanism and conceptual advancement in finding a novel treatment for COVID-19.


ANALES RANM ◽  
2020 ◽  
Vol 137 (137(03)) ◽  
pp. 298-304
Author(s):  
Carlos F Muñoz-Núñez ◽  
Pilar Calvillo-Batllés ◽  
Enrique Zaldívar Olmeda ◽  
Vicente Belloch Ripollés ◽  
Luis Martí-Bonmatí

Coronavirus Disease 2019 (COVID-19) is a highly transmissible and pathogenic viral infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The target organ is the lung. This infection appeared in Wuhan (China) in December 2019 and the WHO considered it a pandemic in March 2020. One year after the first known cases, and although there is a great amount of scientific knowledge acquired of the disease, there are still some unanswered questions. As a matter of fact, there is a lack of knowledge about which patients will suffer sequels, what kind of morphological changes and sequel types will be expected, nor the grade of functional severity. It is known that other coronavirus pneumoniae caused pulmonary sequels and therefore they are expected in COVID-19. In this work we review several COVID-19 aspects related with the development and grading of mid- and long-term pulmonary sequels, including fibrosis and vascular changes, and strengthen the role of medical imaging in this evaluation.


Author(s):  
Lukas Trunz ◽  
Patrick Lee ◽  
Steven Lange ◽  
Corbin Pomeranz ◽  
Laurence Needleman ◽  
...  

The novel coronavirus disease-2019 (COVID-19) illness and deaths, caused by the severe acute respiratory syndrome coronavirus-2, continue to increase. Multiple reports highlight the thromboembolic complications, such as pulmonary embolism (PE), in COVID-19. Imaging plays an essential role in the diagnosis and management of COVID-19 patients with PE. There continues to be a rapid evolution of knowledge related to COVID-19 associated PE. This review summarizes the current understanding of prevalence, pathophysiology, role of diagnostic imaging modalities, and management, including catheter-directed therapy for COVID-19 associated PE. It also describes infection control considerations for the radiology department while providing care for patients with COVID-19 associated PE.


Author(s):  
Ajay Kumar Shukla ◽  
Saurav Misra

Abstract Antibody-dependent enhancement (ADE) can be seen in a variety of viruses. It has a deleterious impact on antibody treatment of viral infection. This effect was first discovered in the dengue virus, and it has since been discovered in the coronavirus. Over 213 million people have been affected by the rapid spread of the newly emerging coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19). The new coronavirus offers a significant threat and has sparked widespread concern. ADE in dengue virus and other viruses are discussed with possible effect on COVID-19 treatment and vaccine development will need to consider this phenomenon to ensure it is mitigated and avoided altogether. In these case scenarios, the role of ADE and its clinical consequences remains to be explored for this newly detected virus.


2012 ◽  
Vol 50 (01) ◽  
Author(s):  
N Lange ◽  
S Sieber ◽  
A Erhardt ◽  
G Sass ◽  
HJ Kreienkamp ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document